Inghirami, Giorgio Ga.

Publications

Sort by

Co-Author Network

selected publications

Long non-coding RNA mitophagy and ALK- anaplastic lymphoma associated transcript: a novel regulator of mitophagy in T cell lymphoma. Haematologica. 2023 Academic Article GET IT
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma. Science translational medicine. 2023 Academic Article GET IT
Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL. Blood. 2023 Academic Article GET IT
Times cited: 5
Primary Effusion Lymphoma in an HIV-Negative Patient with Chronic Myeloid Leukemia Treated with Dasatinib. 2023 GET IT
Combinatorial treatment rescues tumour-microenvironment-mediated attenuation of MALT1 inhibitors in B-cell lymphomas. Nature materials. 2023 Academic Article GET IT
Times cited: 4
In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities. Blood cancer discovery. 2023 Academic Article GET IT
Times cited: 1
Tyrosine kinases in nodal peripheral T-cell lymphomas. Frontiers in oncology. 2023 Review GET IT
Times cited: 33
Endothelial cell-leukemia interactions remodel drug responses, uncovering T-ALL vulnerabilities. Blood. 2023 Academic Article GET IT
Times cited: 1
A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas. The Journal of clinical investigation. 2022 Academic Article GET IT
Times cited: 1
Hyaluronan driven by epithelial aPKC deficiency remodels the microenvironment and creates a vulnerability in mesenchymal colorectal cancer. Cancer cell. 2022 Academic Article GET IT
Times cited: 3
Genomic profiling for clinical decision making in lymphoid neoplasms. Blood. 2022 Academic Article GET IT
Times cited: 21
Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma project. Hematological oncology. 2022 Academic Article GET IT
Times cited: 1
Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2022 Academic Article GET IT
Times cited: 7
Characterization of GECPAR, a noncoding RNA that regulates the transcriptional program of diffuse large B-cell lymphoma. Haematologica. 2022 Academic Article GET IT
Specification of fetal liver endothelial progenitors to functional zonated adult sinusoids requires c-Maf induction. Cell stem cell. 2022 Academic Article GET IT
Times cited: 12
Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion-associated myeloid neoplasm. 2022 GET IT
Times cited: 4
Genetic and phenotypic attributes of splenic marginal zone lymphoma. Blood. 2022 Academic Article GET IT
Times cited: 25
Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment. Frontiers in immunology. 2022 Academic Article GET IT
Times cited: 9
A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas. Blood. 2021 Academic Article GET IT
Times cited: 38
Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking. eLife. 2021 Academic Article GET IT
Times cited: 11
PKCλ/ι inhibition activates an ULK2-mediated interferon response to repress tumorigenesis. Molecular cell. 2021 Academic Article GET IT
Times cited: 7
Oncogenic HSP90 Facilitates Metabolic Alterations in Aggressive B-cell Lymphomas. Cancer research. 2021 Academic Article GET IT
Times cited: 8
Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AML. Frontiers in oncology. 2021 Academic Article GET IT
Times cited: 103
Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project. Blood. 2021 Academic Article GET IT
Times cited: 25
Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 2021 Academic Article GET IT
Times cited: 22
Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target. Haematologica. 2021 Academic Article GET IT
Times cited: 25
Cytoskeleton Dynamics in Peripheral T Cell Lymphomas: An Intricate Network Sustaining Lymphomagenesis. Frontiers in oncology. 2021 Review GET IT
Times cited: 15
In Vivo and Ex Vivo Patient-Derived Tumor Xenograft Models of Lymphoma for Drug Discovery. Current protocols. 2021 Academic Article GET IT
Identification of MALT1 feedback mechanisms enables rational design of potent antilymphoma regimens for ABC-DLBCL. Blood. 2021 Academic Article GET IT
Times cited: 17
Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental Signatures. Cancer discovery. 2021 Academic Article GET IT
Times cited: 68
The DNA-helicase HELLS drives ALK^- ALCL proliferation by the transcriptional control of a cytokinesis-related program. Cell death & disease. 2021 Academic Article GET IT
Times cited: 7
FYN-TRAF3IP2 induces NF-κB signaling-driven peripheral T cell lymphoma. Nature cancer. 2021 Academic Article GET IT
Times cited: 13
Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression. Life science alliance. 2020 Academic Article GET IT
Times cited: 34
Etiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Current Directions in Research. Cancers. 2020 Review GET IT
Times cited: 16
Kinomic profiling of tumour xenografts derived from patients with non-small cell lung cancer confirms their fidelity and reveals potentially actionable pathways. European journal of cancer (Oxford, England : 1990). 2020 Academic Article GET IT
Times cited: 1
Correction: Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma. Leukemia. 2020 Article GET IT
T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma. Blood advances. 2020 Academic Article GET IT
Times cited: 35
Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort. Haematologica. 2020 Academic Article GET IT
Times cited: 12
Longitudinal immune profiling of mild and severe COVID-19 reveals innate and adaptive immune dysfunction and provides an early prediction tool for clinical progression. medRxiv : the preprint server for health sciences. 2020 Article GET IT
Selective dysregulation of ROCK2 activity promotes aberrant transcriptional networks in ABC diffuse large B-cell lymphoma. Scientific reports. 2020 Academic Article GET IT
Times cited: 3
Three-dimensional growth of breast cancer cells potentiates the anti-tumor effects of unacylated ghrelin and AZP-531. eLife. 2020 Academic Article GET IT
Times cited: 5
A Novel JAK1 Mutant Breast Implant-Associated Anaplastic Large Cell Lymphoma Patient-Derived Xenograft Fostering Pre-Clinical Discoveries. Cancers. 2020 Academic Article GET IT
Times cited: 20
Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring. Nature medicine. 2020 Academic Article GET IT
Times cited: 124
Peripheral T cell lymphomas: from the bench to the clinic. Nature reviews. Cancer. 2020 Review GET IT
Times cited: 55
Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia. Nature genetics. 2020 Academic Article GET IT
Times cited: 73
The novel lncRNA BlackMamba controls the neoplastic phenotype of ALK^- anaplastic large cell lymphoma by regulating the DNA helicase HELLS. Leukemia. 2020 Academic Article GET IT
Times cited: 9
Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project. The Lancet. Haematology. 2020 Academic Article GET IT
Times cited: 71
Multiparametric in situ imaging of NPM1-mutated acute myeloid leukemia reveals prognostically-relevant features of the marrow microenvironment. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2020 Academic Article GET IT
Times cited: 5
Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2020 Article GET IT
Times cited: 3
Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer. Cell reports. 2020 Academic Article GET IT
Times cited: 51
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma. Cancer discovery. 2020 Academic Article GET IT
Times cited: 78
Does Breast Implant-Associated ALCL Begin as a Lymphoproliferative Disorder?. Plastic and reconstructive surgery. 2020 Academic Article GET IT
Times cited: 17
Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma. The American journal of pathology. 2019 Review GET IT
Times cited: 26
CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies. Science translational medicine. 2019 Academic Article GET IT
Times cited: 51
Transcriptional Analysis of Lennert Lymphoma Reveals a Unique Profile and Identifies Novel Therapeutic Targets. Frontiers in genetics. 2019 Academic Article GET IT
Times cited: 213
Repurposing dasatinib for diffuse large B cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 2019 Academic Article GET IT
Times cited: 18
Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemia. Leukemia & lymphoma. 2019 Letter GET IT
Times cited: 17
Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2019 Academic Article GET IT
Times cited: 26
Combined use of tofacitinib (pan-JAK inhibitor) and ruxolitinib (a JAK1/2 inhibitor) for refractory T-cell prolymphocytic leukemia (T-PLL) with a JAK3 mutation. 2019 GET IT
Times cited: 18
Author Correction: The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling. Nature cell biology. 2019 Academic Article GET IT
Times cited: 6
Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma. American journal of hematology. 2019 Academic Article GET IT
Times cited: 12
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. Blood. 2019 Academic Article GET IT
Times cited: 142
Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death. Nature. 2019 Academic Article GET IT
Times cited: 194
A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma. Blood. 2019 Academic Article GET IT
Times cited: 50
The Transcriptional Regulator Sin3A Contributes to the Oncogenic Potential of STAT3. Cancer research. 2019 Academic Article GET IT
Times cited: 25
Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesis. Nature immunology. 2018 Academic Article GET IT
Times cited: 53
Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials. Blood cancer journal. 2018 Academic Article GET IT
Times cited: 29
TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis. Cancer discovery. 2018 Academic Article GET IT
Times cited: 101
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells. Molecular therapy. Nucleic acids. 2018 Academic Article GET IT
Times cited: 39
Simple deep sequencing-based post-remission MRD surveillance predicts clinical relapse in B-ALL. Journal of hematology & oncology. 2018 Academic Article GET IT
Times cited: 19
Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma. Leukemia. 2018 Academic Article GET IT
Times cited: 35
PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survival. Blood. 2018 Academic Article GET IT
Times cited: 43
Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth. The Journal of clinical investigation. 2018 Academic Article GET IT
Times cited: 40
Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular Morphology. Applied immunohistochemistry & molecular morphology : AIMM. 2018 Academic Article GET IT
Times cited: 36
Patient derived organoids to model rare prostate cancer phenotypes. Nature communications. 2018 Academic Article GET IT
Times cited: 203
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models. Nature communications. 2018 Academic Article GET IT
Times cited: 63
Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications. British journal of haematology. 2018 Academic Article GET IT
Times cited: 33
Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms. Oncoimmunology. 2018 Academic Article GET IT
Times cited: 11
Cell of origin markers identify different prognostic subgroups of lung adenocarcinoma. Human pathology. 2018 Academic Article GET IT
Times cited: 11
Pathogenesis of Peripheral T Cell Lymphoma. Annual review of pathology. 2018 Review GET IT
Times cited: 27
IRF4 Mediates the Oncogenic Effects of STAT3 in Anaplastic Large Cell Lymphomas. Cancers. 2018 Academic Article GET IT
Times cited: 9141
AICDA drives epigenetic heterogeneity and accelerates germinal center-derived lymphomagenesis. Nature communications. 2018 Academic Article GET IT
Times cited: 42
PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models. Cancer research. 2017 Academic Article GET IT
Times cited: 75
Assessment of T-cell receptor repertoire and clonal expansion in peripheral T-cell lymphoma using RNA-seq data. Scientific reports. 2017 Academic Article GET IT
Times cited: 21
Diffuse large B cell lymphoma cell of origin by digital expression profiling in the REAL07 Phase 1-2 study. British journal of haematology. 2017 Letter GET IT
Times cited: 5
Patient-derived tumor xenografts of lymphoproliferative disorders: are they surrogates for the human disease?. Current opinion in hematology. 2017 Review GET IT
Times cited: 7
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity. Nature communications. 2017 Academic Article GET IT
Times cited: 992
Are we ready to take full advantage of patient-derived tumor xenograft models?. Hematological oncology. 2017 Academic Article GET IT
Times cited: 1
Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomas. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 2017 Academic Article GET IT
Times cited: 14
The heterogeneous landscape of ALK negative ALCL. Oncotarget. 2017 Review GET IT
Times cited: 24
Pulmonary adenocarcinoma with enteric differentiation: Dissecting oncogenic genes alterations with DNA sequencing and FISH analysis. Experimental and molecular pathology. 2017 Academic Article GET IT
Times cited: 15
Corrigendum: THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors. Nature communications. 2017 Academic Article GET IT
Times cited: 4
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors. Nature communications. 2017 Academic Article GET IT
Times cited: 68
Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas. Proceedings of the National Academy of Sciences of the United States of America. 2017 Academic Article GET IT
Times cited: 82
OTX015 (MK-8628), a novel BET inhibitor, exhibits antitumor activity in non-small cell and small cell lung cancer models harboring different oncogenic mutations. Oncotarget. 2016 Academic Article GET IT
Times cited: 38
Molecular Checkpoint Decisions Made by Subverted Vascular Niche Transform Indolent Tumor Cells into Chemoresistant Cancer Stem Cells. Cancer cell. 2016 Academic Article GET IT
Times cited: 82
Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypes. Oncotarget. 2016 Academic Article GET IT
Times cited: 19
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment. Blood advances. 2016 Academic Article GET IT
Corrigendum: Stromal contribution to the colorectal cancer transcriptome. Nature genetics. 2016 Academic Article GET IT
Times cited: 5
The novel PI3K-δ inhibitor TGR-1202 enhances Brentuximab Vedotin-induced Hodgkin lymphoma cell death via mitotic arrest. Leukemia. 2016 Letter GET IT
Times cited: 13
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice. Cancer cell. 2016 Academic Article GET IT
Times cited: 33
Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma. Oncotarget. 2016 Academic Article GET IT
Times cited: 15
Transposable elements: The enemies within. Experimental hematology. 2016 Review GET IT
Times cited: 1
The genetics of nodal marginal zone lymphoma. Blood. 2016 Academic Article GET IT
Times cited: 114
Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cells. Leukemia. 2016 Review GET IT
Times cited: 22
Oncogenic kinase fusions: an evolving arena with innovative clinical opportunities. Oncotarget. 2016 Review GET IT
Times cited: 14
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice. Cancer cell. 2016 Academic Article GET IT
Times cited: 176
The Influence of Tissue Ischemia Time on RNA Integrity and Patient-Derived Xenografts (PDX) Engraftment Rate in a Non-Small Cell Lung Cancer (NSCLC) Biobank. PloS one. 2016 Academic Article GET IT
Times cited: 35
Combinatorial targeting of nuclear export and translation of RNA inhibits aggressive B-cell lymphomas. Blood. 2015 Academic Article GET IT
Times cited: 57
Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts. Blood. 2015 Academic Article GET IT
Times cited: 73
Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors. Cancer immunology research. 2015 Academic Article GET IT
Times cited: 34
Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR. The Journal of molecular diagnostics : JMD. 2015 Academic Article GET IT
Times cited: 109
JAK-STAT in lymphoproliferative disorders. Oncoscience. 2015 Academic Article GET IT
Times cited: 158
Anaplastic lymphoma kinase inhibitors. Current opinion in pharmacology. 2015 Review GET IT
Times cited: 18
Anaplastic lymphoma kinase: activating mechanisms and signaling pathways. Frontiers in bioscience (Scholar edition). 2015 Review GET IT
Times cited: 1
Epigenomic evolution in diffuse large B-cell lymphomas. Nature communications. 2015 Academic Article GET IT
Times cited: 95
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma. Cancer cell. 2015 Academic Article GET IT
Times cited: 329
Cytokine-induced killer cells engineered with exogenous T-cell receptors directed against melanoma antigens: enhanced efficacy of effector cells endowed with a double mechanism of tumor recognition. Human gene therapy. 2015 Academic Article GET IT
Times cited: 14
Stromal contribution to the colorectal cancer transcriptome. Nature genetics. 2015 Academic Article GET IT
Times cited: 454
The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs. Clinical cancer research : an official journal of the American Association for Cancer Research. 2015 Academic Article GET IT
Times cited: 213
Advances in understanding the pathogenesis of systemic anaplastic large cell lymphomas. British journal of haematology. 2015 Review GET IT
Times cited: 42
Peripheral T-cell and NK cell lymphoproliferative disorders: cell of origin, clinical and pathological implications. Immunological reviews. 2015 Review GET IT
Times cited: 27
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation. Leukemia. 2014 Academic Article GET IT
Times cited: 34
The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling. Nature cell biology. 2014 Academic Article GET IT
Times cited: 86
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells. Blood. 2014 Academic Article GET IT
Times cited: 237
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells. Blood. 2014 Academic Article GET IT
Times cited: 71
Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified. Blood cancer journal. 2014 Academic Article GET IT
Times cited: 25
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. Blood. 2014 Academic Article GET IT
Times cited: 129
PRDM1/BLIMP1: a tumor suppressor gene in B and T cell lymphomas. Leukemia & lymphoma. 2014 Review GET IT
Times cited: 42
The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. Leukemia. 2014 Letter GET IT
Times cited: 72
Pegasus: a comprehensive annotation and prediction tool for detection of driver gene fusions in cancer. BMC systems biology. 2014 Academic Article GET IT
Times cited: 48
Microscale Bioadhesive Hydrogel Arrays for Cell Engineering Applications. Cellular and molecular bioengineering. 2014 Academic Article GET IT
Times cited: 106
Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial. The Lancet. Oncology. 2014 Academic Article GET IT
Times cited: 149
ALK/EML4 fusion gene may be found in pure squamous carcinoma of the lung. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2014 Academic Article GET IT
Times cited: 46
Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway. Leukemia. 2014 Academic Article GET IT
Times cited: 32
Genetics of follicular lymphoma transformation. Cell reports. 2014 Academic Article GET IT
Times cited: 400
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma. Blood. 2013 Academic Article GET IT
Times cited: 288
Molecular events underlying interleukin-6 independence in a subclone of the CMA-03 multiple myeloma cell line. Genes, chromosomes & cancer. 2013 Academic Article GET IT
Times cited: 5
Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia. Leukemia. 2013 Academic Article GET IT
Times cited: 93
PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma. Blood. 2013 Academic Article GET IT
Times cited: 87
Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome. Blood. 2013 Academic Article GET IT
Times cited: 189
STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma. Haematologica. 2013 Academic Article GET IT
Times cited: 43
Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma. Cancer discovery. 2013 Academic Article GET IT
Times cited: 149
Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma. Blood. 2013 Academic Article GET IT
Times cited: 38
Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Academic Article GET IT
Times cited: 103
Beyond NPM-anaplastic lymphoma kinase driven lymphomagenesis: alternative drivers in anaplastic large cell lymphoma. Current opinion in hematology. 2013 Review GET IT
Times cited: 17
MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma. Blood. 2013 Academic Article GET IT
Times cited: 77
Comparative analysis of cancer vaccine settings for the selection of an effective protocol in mice. Journal of translational medicine. 2013 Academic Article GET IT
Times cited: 21
The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1. Oncogenesis. 2013 Academic Article GET IT
Times cited: 26
Core binding factor acute myeloid leukaemia and c-KIT mutations. Oncology reports. 2013 Academic Article GET IT
Times cited: 28
Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia. Haematologica. 2013 Academic Article GET IT
Times cited: 64
The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia. Haematologica. 2013 Academic Article GET IT
Times cited: 169
PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas. Nature medicine. 2012 Academic Article GET IT
Times cited: 99
Stem cells based therapy in high grade glioma: why the intraventricular route should be preferred?. Journal of neurosurgical sciences. 2012 Academic Article GET IT
Times cited: 11
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. The Journal of experimental medicine. 2012 Academic Article GET IT
Times cited: 309
Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma. Blood. 2012 Academic Article GET IT
Times cited: 85
Genetic alterations in systemic nodal and extranodal non-cutaneous lymphomas derived from mature T cells and natural killer cells. Cancer science. 2012 Academic Article GET IT
Times cited: 7
ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma. Frontiers in oncology. 2012 Academic Article GET IT
Times cited: 117
Retinoic acid/alpha-interferon combination inhibits growth and promotes apoptosis in mantle cell lymphoma through Akt-dependent modulation of critical targets. Cancer research. 2012 Academic Article GET IT
Times cited: 19
CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers. Molecular cancer therapeutics. 2011 Academic Article GET IT
Times cited: 63
Loss of p27KIP1 expression in fully-staged node-negative breast cancer: association with lack of hormone receptors in T1a/b, but not T1c infiltrative ductal carcinoma. Anticancer research. 2011 Academic Article GET IT
Times cited: 5
Integrated DNA copy number and methylation profiling of lymphoid neoplasms using a single array. British journal of haematology. 2011 Academic Article GET IT
Times cited: 9
Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation. Blood. 2011 Academic Article GET IT
Times cited: 146
CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death. Blood. 2011 Academic Article GET IT
Times cited: 121
Anaplastic large-cell lymphoma. Seminars in diagnostic pathology. 2011 Review GET IT
Times cited: 28
Anaplastic lymphoma kinase in human cancer. Journal of molecular endocrinology. 2011 Review GET IT
Times cited: 101
Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion. Annals of oncology : official journal of the European Society for Medical Oncology. 2011 Academic Article GET IT
Times cited: 18
BRAF mutations in hairy-cell leukemia. 2011 GET IT
Times cited: 830
Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects. Leukemia & lymphoma. 2011 Academic Article GET IT
Times cited: 12
The lymphoma-associated NPM-ALK oncogene elicits a p16INK4a/pRb-dependent tumor-suppressive pathway. Blood. 2011 Academic Article GET IT
Times cited: 23
Integrated profiling of diffuse large B-cell lymphoma with 7q gain. British journal of haematology. 2011 Academic Article GET IT
Times cited: 11
Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome. Hematological oncology. 2011 Academic Article GET IT
Times cited: 26
Pathobiology of anaplastic large cell lymphoma. Advances in hematology. 2011 Academic Article GET IT
Times cited: 21
Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21. British journal of haematology. 2010 Academic Article GET IT
Times cited: 42
Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas. Hematological oncology. 2010 Academic Article GET IT
Times cited: 42
Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma. British journal of haematology. 2010 Academic Article GET IT
Times cited: 43
Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Academic Article GET IT
Times cited: 136
Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma?. Hematological oncology. 2009 Review GET IT
Times cited: 58
NPM-ALK oncogenic tyrosine kinase controls T-cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells. Cancer research. 2009 Academic Article GET IT
Times cited: 75
Genome wide DNA-profiling of HIV-related B-cell lymphomas. British journal of haematology. 2009 Academic Article GET IT
Times cited: 57
Epidermal growth factor receptor gene in primary tumor and metastatic sites from non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2009 Academic Article GET IT
Times cited: 66
Anaplastic lymphoma kinase: an oncogene for tumor vaccination. Journal of molecular medicine (Berlin, Germany). 2009 Review GET IT
Times cited: 11
The anaplastic lymphoma kinase controls cell shape and growth of anaplastic large cell lymphoma through Cdc42 activation. Cancer research. 2008 Academic Article GET IT
Times cited: 49
The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL. Blood. 2008 Academic Article GET IT
Times cited: 44
The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination. Nature medicine. 2008 Academic Article GET IT
Times cited: 102
Collection, banking and diagnostic archiving of tissues. Pathologica. 2008 Review GET IT
Times cited: 3
The anaplastic lymphoma kinase in the pathogenesis of cancer. Nature reviews. Cancer. 2008 Review GET IT
Times cited: 715
CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib. Blood. 2007 Academic Article GET IT
Times cited: 231
The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration. Cancer research. 2007 Academic Article GET IT
Times cited: 74
Identification and validation of the anaplastic large cell lymphoma signature. Advances in experimental medicine and biology. 2007 Academic Article GET IT
Times cited: 4
Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes. The Journal of clinical investigation. 2006 Academic Article GET IT
Times cited: 132
p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling. Cancer research. 2006 Academic Article GET IT
Times cited: 33
Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell. 2006 Academic Article GET IT
Times cited: 372
Epistaxis and severe weakness in a patient with multiple myeloma. Therapy-related acute myeloid leukemia, pure erythroid leukemia. 2006 GET IT
Times cited: 4
STAT3: a multifaceted oncogene. Proceedings of the National Academy of Sciences of the United States of America. 2006 Comment GET IT
Times cited: 87
Increase in circulating bone marrow progenitor cells after myocardial infarction. Coronary artery disease. 2006 Academic Article GET IT
Times cited: 14
New and old functions of STAT3: a pivotal target for individualized treatment of cancer. Cell cycle (Georgetown, Tex.). 2005 Review GET IT
Times cited: 112
Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas. Blood. 2005 Academic Article GET IT
Times cited: 122
p130Cas mediates the transforming properties of the anaplastic lymphoma kinase. Blood. 2005 Academic Article GET IT
Times cited: 66
Follicular origin of a subset of CD5+ diffuse large B-cell lymphomas. American journal of clinical pathology. 2005 Academic Article GET IT
Times cited: 20
Primary hepatic anaplastic large-cell lymphoma diagnosed by fine-needle aspiration biopsy. Diagnostic cytopathology. 2005 Academic Article GET IT
Times cited: 3
Phase III randomized trial of patient-specific vaccination for previously untreated patients with follicular lymphoma in first complete remission: protocol summary and interim report. Clinical lymphoma. 2005 Academic Article GET IT
Times cited: 24
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. Nature medicine. 2005 Academic Article GET IT
Times cited: 374
A DeImmunized chimeric anti-C3b/iC3b monoclonal antibody enhances rituximab-mediated killing in NHL and CLL cells via complement activation. Cancer immunology, immunotherapy : CII. 2005 Academic Article GET IT
Times cited: 18
Tim-3+ T-bet+ tumor-specific Th1 cells colocalize with and inhibit development and growth of murine neoplasms. Journal of immunology (Baltimore, Md. : 1950). 2005 Academic Article GET IT
Times cited: 24
Transient atypical monocytosis mimic acute myelomonocytic leukemia in post-chemotherapy patients receiving G-CSF: report of two cases. Clinical and laboratory haematology. 2004 Academic Article GET IT
Times cited: 13
The Rgr oncogene induces tumorigenesis in transgenic mice. Cancer research. 2004 Academic Article GET IT
Times cited: 10
BRAF gene is not mutated in plasma cell leukemia and multiple myeloma. Leukemia. 2003 Letter GET IT
Times cited: 16
Differential amplification and overexpression of HER-2/neu, p53, MIB1, and estrogen receptor/progesterone receptor among medullary carcinoma, atypical medullary carcinoma, and high-grade invasive ductal carcinoma of breast. Archives of pathology & laboratory medicine. 2003 Academic Article GET IT
Times cited: 21
The B cell SH2/PH domain-containing adaptor Bam32/DAPP1 is required for T cell-independent II antigen responses. Current biology : CB. 2003 Academic Article GET IT
Times cited: 38
Role of CD30 in the maturation of thymocytes and in the pathogenesis of autoimmune diseases. Pathologica. 2003 Academic Article GET IT
Constitutive expression of DeltaN-p63alpha isoform in human thymus and thymic epithelial tumours. Virchows Archiv : an international journal of pathology. 2003 Academic Article GET IT
Times cited: 41
Identification of oligoclonal CD4 T cells in diffuse large B cell lymphomas. Clinical immunology (Orlando, Fla.). 2003 Academic Article GET IT
Times cited: 5
T-cell clonality and myelodysplasia without chromosomal fragility in a patient with features of Seckel syndrome. 2003 GET IT
Times cited: 15
In vivo interference with Skp1 function leads to genetic instability and neoplastic transformation. Molecular and cellular biology. 2002 Academic Article GET IT
Times cited: 47
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. Blood. 2002 Academic Article GET IT
Times cited: 222
Human rgr: transforming activity and alteration in T-cell malignancies. Oncogene. 2002 Academic Article GET IT
Times cited: 11
S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase. The American journal of pathology. 2002 Academic Article GET IT
Times cited: 102
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death. Oncogene. 2002 Academic Article GET IT
Times cited: 324
Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2002 Academic Article GET IT
Times cited: 100
Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. The Journal of experimental medicine. 2001 Academic Article GET IT
Times cited: 785
Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia. Blood. 2001 Academic Article GET IT
Times cited: 163
Role of the F-box protein Skp2 in lymphomagenesis. Proceedings of the National Academy of Sciences of the United States of America. 2001 Academic Article GET IT
Times cited: 269
Induction of germinal centers by MMTV encoded superantigen on B cells. Developmental immunology. 2001 Academic Article GET IT
Times cited: 6
The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer. Breast cancer research : BCR. 2000 Review GET IT
Times cited: 84
CD5+ follicle center lymphoma. Immunophenotyping detects a unique subset of "floral" follicular lymphoma. American journal of clinical pathology. 2000 Academic Article GET IT
Times cited: 39
Low expression of p27 and low proliferation index do not correlate in hairy cell leukaemia. British journal of haematology. 2000 Academic Article GET IT
Times cited: 21
Initiation of translation from a downstream in-frame AUG codon on BRCA1 can generate the novel isoform protein DeltaBRCA1(17aa). Oncogene. 2000 Academic Article GET IT
Times cited: 20
Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma. Blood. 2000 Academic Article GET IT
Times cited: 190
Five human genes encoding F-box proteins: chromosome mapping and analysis in human tumors. Cytogenetics and cell genetics. 2000 Academic Article GET IT
Times cited: 25
Molecular pathogenesis of B-cell chronic lymphocytic leukemia: analysis of 13q14 chromosomal deletions. Current topics in microbiology and immunology. 2000 Review GET IT
Times cited: 10
Molecular features of primary mediastinal B-cell lymphoma: involvement of p16INK4A, p53 and c-myc. British journal of haematology. 1999 Academic Article GET IT
Times cited: 41
Detection of immunoglobulin kappa light chain rearrangements by polymerase chain reaction. An improved method for detecting clonal B-cell lymphoproliferative disorders. The American journal of pathology. 1999 Academic Article GET IT
Times cited: 50
CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via a Bcl-2-sensitive pathway. Journal of immunology (Baltimore, Md. : 1950). 1999 Academic Article GET IT
Times cited: 94
Tubular Carcinoma of the Breast: Immunohistochemical and DNA Flow Cytometric Profile. The breast journal. 1999 Academic Article GET IT
Times cited: 12
pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells. The Journal of biological chemistry. 1999 Academic Article GET IT
Times cited: 205
CD30 in normal and neoplastic cells. Clinical immunology (Orlando, Fla.). 1999 Review GET IT
Times cited: 150
The usefulness of immunophenotypic and genotypic studies in the diagnosis and classification of hematopoietic and lymphoid neoplasms. An update. American journal of clinical pathology. 1999 Review GET IT
Times cited: 36
Differential expression of cyclin-dependent kinase 6 in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia. The American journal of pathology. 1998 Academic Article GET IT
Times cited: 93
Chromosomal mapping to 15q14 and expression analysis of the human MEIS2 homeobox gene. Mammalian genome : official journal of the International Mammalian Genome Society. 1997 Academic Article GET IT
Times cited: 9
Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. Blood. 1997 Academic Article GET IT
Times cited: 181
Lymphocyte-rich well-differentiated liposarcoma: report of nine cases. The American journal of surgical pathology. 1997 Academic Article GET IT
Times cited: 70
Cloning and mapping of the MEIS1 gene, the human homolog of a murine leukemogenic gene. Genomics. 1997 Academic Article GET IT
Times cited: 27
p21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: a potential marker of p53 tumor-suppressor gene function. Blood. 1996 Academic Article GET IT
Times cited: 71
Morphological and biological characteristics of mammogram-detected invasive breast cancer. Human pathology. 1996 Academic Article GET IT
Times cited: 16
Large-cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome. British journal of haematology. 1996 Academic Article GET IT
Times cited: 75
Molecular characterization of the t(2;5) (p23; q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease. Blood. 1996 Academic Article GET IT
Times cited: 62
The physiology of germinal centers. Critical reviews in immunology. 1996 Review GET IT
Times cited: 53
In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood. 1995 Academic Article GET IT
Times cited: 518
Clonal analysis of IgM+ CD5+ CLL B cells. Annals of the New York Academy of Sciences. 1995 Academic Article GET IT
Times cited: 1
Breast cancer heterogeneity: evaluation of clonality in primary and metastatic lesions. Human pathology. 1995 Academic Article GET IT
Times cited: 81
The Reed-Sternberg cells of Hodgkin disease are clonal. Proceedings of the National Academy of Sciences of the United States of America. 1994 Academic Article GET IT
Times cited: 48
N- and K-ras oncogenes in plasma cell dyscrasias. Leukemia & lymphoma. 1994 Review GET IT
Times cited: 27
Phenotypic and functional characterization of T-BAM (CD40 ligand)+ T-cell non-Hodgkin's lymphoma. Blood. 1994 Academic Article GET IT
Times cited: 13
Molecular characterization of CD30+ anaplastic large-cell lymphoma: high frequency of c-myc proto-oncogene activation. Blood. 1994 Academic Article GET IT
Times cited: 62
Role of the bcl-2 oncogene in Hodgkin's disease. American journal of clinical pathology. 1994 Editorial Article GET IT
Times cited: 12
Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias. Leukemia. 1994 Academic Article GET IT
Times cited: 100
Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma). Blood. 1994 Academic Article GET IT
Times cited: 115
T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death. Journal of immunology (Baltimore, Md. : 1950). 1994 Academic Article GET IT
Times cited: 111
CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L. Potential role in regulating helper effector function. Journal of immunology (Baltimore, Md. : 1950). 1994 Academic Article GET IT
Times cited: 202
Anti-Hu-associated peripheral nerve and muscle microvasculitis. 1994 GET IT
Times cited: 82
Naturally processed cytokine-derived peptide bound to HLA-class II molecules. Journal of immunology (Baltimore, Md. : 1950). 1993 Academic Article GET IT
Times cited: 12
High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma. The American journal of pathology. 1993 Academic Article GET IT
Times cited: 118
Detection of immunoglobulin gene rearrangement of B cell non-Hodgkin's lymphomas and leukemias in fresh, unfixed and formalin-fixed, paraffin-embedded tissue by polymerase chain reaction. Laboratory investigation; a journal of technical methods and pathology. 1993 Academic Article GET IT
Times cited: 102
Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias. Blood. 1993 Academic Article GET IT
Times cited: 121
Major histocompatibility complex-restricted recognition of autologous chronic lymphocytic leukemia by tumor-specific T cells. 1993 GET IT
Times cited: 9
Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help. Journal of immunology (Baltimore, Md. : 1950). 1992 Academic Article GET IT
Times cited: 195
Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations. Blood. 1992 Academic Article GET IT
Times cited: 114
Determination of the DNA content of the Reed-Sternberg cell of Hodgkin's disease by image analysis. Blood. 1992 Academic Article GET IT
Times cited: 14
Neurolymphomatosis: a clinicopathologic syndrome re-emerges. 1992 GET IT
Times cited: 104
Large-cell acanthoma. A distinctive keratosis. The American Journal of dermatopathology. 1992 Academic Article GET IT
Times cited: 17
T-cell activation-associated antigen expression by neoplastic T-cells. Hematologic pathology. 1992 Academic Article GET IT
Times cited: 10
The kinetics and temporal expression of T-cell activation-associated antigens CD15 (LeuM1), CD30 (Ki-1), EMA, and CD11c (LeuM5) by benign activated T cells. Hematologic pathology. 1992 Academic Article GET IT
Times cited: 38
Autoantibody-associated cross-reactive idiotype-bearing human B lymphocytes: distribution and characterization, including Ig VH gene and CD5 antigen expression. Blood. 1991 Academic Article GET IT
Times cited: 23
Does a retrovirus cause amyotrophic lateral sclerosis?. Annals of neurology. 1991 Letter GET IT
Times cited: 15
p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America. 1991 Academic Article GET IT
Times cited: 844
Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphoma. Blood. 1991 Academic Article GET IT
Times cited: 182
Lymphoma, motor neuron diseases, and amyotrophic lateral sclerosis. Annals of neurology. 1991 Academic Article GET IT
Times cited: 124
The B-cells that express anti-MAG antibodies in neuropathy and non-malignant IgM monoclonal gammopathy belong to the CD5 subpopulation. Journal of neuroimmunology. 1991 Academic Article GET IT
Times cited: 24
Negative autoregulation of c-myc gene expression is inactivated in transformed cells. The EMBO journal. 1990 Academic Article GET IT
Times cited: 87
Down-regulation of LFA-1 adhesion receptors by C-myc oncogene in human B lymphoblastoid cells. Science (New York, N.Y.). 1990 Academic Article GET IT
Times cited: 116
Western thymomas lack Epstein-Barr virus by Southern blotting analysis and by polymerase chain reaction. The American journal of pathology. 1990 Academic Article GET IT
Times cited: 32
Flow cytometric and immunohistochemical characterization of the gamma/delta T-lymphocyte population in normal human lymphoid tissue and peripheral blood. The American journal of pathology. 1990 Academic Article GET IT
Times cited: 65
Hairy cell leukemia-associated antigen LeuM5 (CD11c) is preferentially expressed by benign activated and neoplastic CD8 T cells. The American journal of pathology. 1990 Academic Article GET IT
Times cited: 8
Mechanism of negative feed-back regulation of c-myc gene expression in B-cells and its inactivation in tumor cells. Current topics in microbiology and immunology. 1990 Academic Article GET IT
Times cited: 4
Extranodal noncutaneous lymphoid hyperplasias represent a continuous spectrum of B-cell neoplasia: demonstration by molecular genetic analysis. Blood. 1989 Academic Article GET IT
Times cited: 75
Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. 1989 GET IT
Times cited: 276
Transformation and plasmacytoid differentiation of EBV-infected human B lymphoblasts by ras oncogenes. Science (New York, N.Y.). 1989 Academic Article GET IT
Times cited: 62
Immunoglobulin VH gene expression in human B cell lines and tumors: biased VH gene expression in chronic lymphocytic leukemia. International immunology. 1989 Academic Article GET IT
Times cited: 96
Differential expression of LFA-1 molecules in non-Hodgkin's lymphoma and lymphoid leukemia. Blood. 1988 Academic Article GET IT
Times cited: 96
Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood. 1988 Academic Article GET IT
Times cited: 229
Model for studying virus attachment: identification and quantitation of Epstein-Barr virus-binding cells by using biotinylated virus in flow cytometry. Journal of virology. 1988 Academic Article GET IT
Times cited: 62
Immunoregulatory aberrations in patients with polyarticular juvenile rheumatoid arthritis. Clinical immunology and immunopathology. 1988 Academic Article GET IT
Times cited: 24
High dose intravenous methotrexate with leucovorin rescue in rheumatoid arthritis. The Journal of rheumatology. 1988 Academic Article GET IT
Times cited: 11
Activated T lymphocytes in the peripheral blood of patients with systemic lupus erythematosus induce B cells to produce immunoglobulin. Clinical and experimental rheumatology. 1988 Academic Article GET IT
Times cited: 49
Different biological effects of c-myc and H-ras oncogene expression in EBV-infected human lymphoblasts. Current topics in microbiology and immunology. 1988 Academic Article GET IT
Times cited: 2
In vitro generated human monoclonal trinitrophenyl-specific B cell lines. Evidence that human and murine anti-trinitrophenyl monoclonal antibodies cross-react with Escherichia coli beta-galactosidase. Journal of immunology (Baltimore, Md. : 1950). 1987 Academic Article GET IT
Times cited: 8
Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset. Science (New York, N.Y.). 1987 Academic Article GET IT
Times cited: 434
Cellular immunity in patients with systemic juvenile rheumatoid arthritis. Clinical immunology and immunopathology. 1987 Academic Article GET IT
Times cited: 17
Human monoclonals from antigen-specific selection of B lymphocytes and transformation by EBV. Science (New York, N.Y.). 1986 Academic Article GET IT
Times cited: 77
Complement receptors (CR) and cytotoxic responses: monoclonal antibodies directed against CR1 and CR3 inhibit the generation of human allospecific and virus specific cytotoxic cells in vitro. Journal of immunopharmacology. 1986 Academic Article GET IT
Regulation of human cytotoxic responses by complement: C3, C3b and C3d preparations enhance human allogeneic cytotoxic responses. Journal of immunopharmacology. 1986 Academic Article GET IT
Times cited: 4
Regulation of immunoglobulin secretion by factor H of human complement. Immunology. 1985 Academic Article GET IT
Times cited: 16
Enhancement of human allogeneic cytotoxic responses by interferons. Journal of immunopharmacology. 1985 Academic Article GET IT
Times cited: 4
Monoclonal antibodies to breast cancer-associated antigens as potential reagents in the management of breast cancer. Cancer. 1984 Academic Article GET IT
Times cited: 44
Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma. 1984 Academic Article GET IT
Times cited: 502

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

Vividion Therapeutics Biopharma Agreement awarded by Vividion Therapeutics, Inc. Principal Investigator 2023 - 2023
Inghirami Kymera BP awarded by Kymera Therapeutics, Inc. Principal Investigator 2021 - 2023

Targeting Latency Switch in EBV+ Lymphomas awarded by National Cancer Institute Co-Investigator 2022 - 2027
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study awarded by Genentech, Inc. Co-Investigator 2021 - 2026
Therapeutic targeting of breast cancer and host immune responses at inflection points in the disease trajectory awarded by United States Department of Defense Co-Investigator 2021 - 2025
Role of the stromal microenvironment in B-cell lymphoma progression and immune escape awarded by National Cancer Institute Co-Investigator 2019 - 2024
Mechanism-Based Targeting of Mantle Cell Lymphoma awarded by National Cancer Institute Co-Investigator 2018 - 2024
Converting HR+ Breast Cancer Into an Individualized Vaccine awarded by United States Department of Defense Co-Investigator 2019 - 2023
Longitudinal functional genomics in mantle cell lymphoma therapy and drug resistance awarded by Leukemia & Lymphoma Society, Inc. Co-Investigator 2018 - 2023
Harnessing the CRL4 Ubiquitin Ligase for Antagonizing Colorectal Carcinogenesis awarded by National Cancer Institute Co-Investigator 2017 - 2023

Targeting Unmet Needs For B-cell Lymphomas awarded by Leukemia & Lymphoma Society, Inc. Key Personnel 2022 - 2027
Generation of fully humanized murine avatars of B-ALL patients for the study of refractoriness and relapse in a bedside approach awarded by American Italian Cancer Foundation Key Personnel 2023 - 2024
Characteristics and Outcomes of Patients with Follicular Lymphoma with at Least Two Prior Lines of Systemic Therapy and Treated at Cancer Centers within the LEO Cohort awarded by Genentech, Inc. Key Personnel 2022 - 2024
DEVELOPMENT OF NEW MODELS OF THYMIC EPITHELIAL TUMORS awarded by Thymic Carcinoma Center Key Personnel 2022 - 2023
Immunologic Eradication of Myeloproliferative Neoplasm Stem Cells awarded by Daedalus Fund for Innovation (Weill Cornell) Key Personnel 2022 - 2023
Modulation Of Viral Latency In EBV+ Lymphomas To Sensitize Tumors To Immunotherapy awarded by American Society of Hematology Inc Key Personnel 2021 - 2023

Translational Discovery in Peripheral T-Cell Lymphomas awarded by National Institute of Diabetes & Digestive & Kidney Diseases Principal Investigator Subaward 2022 - 2026
The Impact of Changes in Chromatin Architecture on Cancer Phenotypes and Tumor Progression (Core 3) awarded by National Heart, Lung, & Blood Institute Principal Investigator Subaward 2019 - 2024
Molecular Diagnosis, Prognosis and Therapeutic Targets in Lymphoma (Core 3) awarded by Genentech, Inc. Principal Investigator Subaward 2018 - 2023

more ...

less ...

Background

education and training

M.D., University of Turin Faculty of Medicine and Surgery (Italy) 1981

Contact

full name

Giorgio Ga. Inghirami

primary email

ggi9001@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Giorgio Ga. Inghirami Professor of Pathology and Laboratory Medicine

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

webpage